ANA Test & Lupus: Positive ANA ≠ Lupus Diagnosis

A positive antinuclear antibody (ANA) test is sensitive but not specific for systemic lupus erythematosus (SLE).

Key Points

• Sensitivity: 95–98% of SLE patients are ANA+.
• Specificity: Low — positive in other autoimmune diseases (Sjögren's, scleroderma, MCTD, RA, autoimmune hepatitis), infections (EBV, HIV, HCV), drugs (hydralazine, procainamide, TNF inhibitors), and 5–15% of healthy people (titers usually low).
• Titer & pattern matter: High titer (≥1:640) + specific pattern (homogeneous, speckled, centromere, nucleolar) increases predictive value.

Diagnosis Requires

2019 EULAR/ACR criteria: Clinical criteria (rash, arthritis, serositis, renal, neurologic, hematologic) + immunologic criteria (ANA entry criterion + anti-dsDNA, anti-Smith, antiphospholipid, low complement, direct Coombs). ANA alone is insufficient.

Clinical Action

Positive ANA + suggestive symptoms → refer to rheumatology. Isolated low-titer ANA in asymptomatic person → usually monitor, not treat.